Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 3
1983 1
1984 1
1985 1
1987 1
1988 2
1989 1
2007 1
2009 3
2010 1
2012 2
2013 1
2014 2
2017 2
2018 2
2019 5
2020 3
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Dapagliflozin in Patients with Chronic Kidney Disease.
Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, Sjöström CD, Toto RD, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Heerspink HJL, et al. N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24. N Engl J Med. 2020. PMID: 32970396 Free article. Clinical Trial.
The role of complement in IgA nephropathy.
Tortajada A, Gutierrez E, Pickering MC, Praga Terente M, Medjeral-Thomas N. Tortajada A, et al. Among authors: praga terente m. Mol Immunol. 2019 Oct;114:123-132. doi: 10.1016/j.molimm.2019.07.017. Epub 2019 Jul 24. Mol Immunol. 2019. PMID: 31351413 Free article. Review.
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G, Ouyang J, McQuade RD, Blais JD, Czerwiec FS, Sergeyeva O; REPRISE Trial Investigators. Torres VE, et al. N Engl J Med. 2017 Nov 16;377(20):1930-1942. doi: 10.1056/NEJMoa1710030. Epub 2017 Nov 4. N Engl J Med. 2017. PMID: 29105594 Free article. Clinical Trial.
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function.
Heerspink HJL, Cherney D, Postmus D, Stefánsson BV, Chertow GM, Dwyer JP, Greene T, Kosiborod M, Langkilde AM, McMurray JJV, Correa-Rotter R, Rossing P, Sjöström CD, Toto RD, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Heerspink HJL, et al. Kidney Int. 2022 Jan;101(1):174-184. doi: 10.1016/j.kint.2021.09.005. Epub 2021 Sep 22. Kidney Int. 2022. PMID: 34560136 Free article. Clinical Trial.
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial.
Heerspink HJL, Sjöström CD, Jongs N, Chertow GM, Kosiborod M, Hou FF, McMurray JJV, Rossing P, Correa-Rotter R, Kurlyandskaya R, Stefansson BV, Toto RD, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators. Heerspink HJL, et al. Eur Heart J. 2021 Mar 31;42(13):1216-1227. doi: 10.1093/eurheartj/ehab094. Eur Heart J. 2021. PMID: 33792669 Free PMC article. Clinical Trial.
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
C3 glomerulopathies. A new perspective on glomerular diseases.
Rabasco-Ruiz C, Huerta-Arroyo A, Caro-Espada J, Gutiérrez-Martínez E, Praga-Terente M. Rabasco-Ruiz C, et al. Among authors: praga terente m. Nefrologia. 2013;33(2):164-70. doi: 10.3265/Nefrologia.pre2012.Nov.11802. Nefrologia. 2013. PMID: 23511752 Free article. Review. English, Spanish.
Does renal function improve after parathyroidectomy in primary hyperparathyroidism?
García-Martín F, Guadalix S, García-Boyano F, Melón Peña N, Martínez Pueyo JI, Callejas Martínez R, Praga Terente M. García-Martín F, et al. Among authors: praga terente m. Nefrologia (Engl Ed). 2019 Mar-Apr;39(2):160-167. doi: 10.1016/j.nefro.2018.08.007. Epub 2018 Nov 17. Nefrologia (Engl Ed). 2019. PMID: 30459009 Free article. English, Spanish.
Long-term plasmapheresis therapy in the management of focal segmental glomerulosclerosis recurrence after kidney transplantation.
Ramirez-Guerrero G, Sevillano Prieto AM, Jara-Vilugrón F, Polanco Fernandez N, Gonzalez Monte E, Henandez Vicente A, Rodriguez Gayo LC, Praga Terente M, Andrés Belmonte A. Ramirez-Guerrero G, et al. Among authors: praga terente m. Transfus Apher Sci. 2021 Apr;60(2):103046. doi: 10.1016/j.transci.2020.103046. Epub 2021 Jan 2. Transfus Apher Sci. 2021. PMID: 33455879
Tuberculous interstitial nephritis: A difficult diagnosis that requires a high clinical suspicion.
Fernández-Vidal M, Canllavi Fiel E, Bada Bosch T, Trujillo Cuéllar H, García Martín F, Gutiérrez Martínez E, Molina Gómez M, Alonso Riaño M, Praga Terente M. Fernández-Vidal M, et al. Among authors: praga terente m. Nefrologia (Engl Ed). 2020 Jul-Aug;40(4):475-477. doi: 10.1016/j.nefro.2019.05.002. Epub 2019 Oct 10. Nefrologia (Engl Ed). 2020. PMID: 31606161 Free article. English, Spanish. No abstract available.
31 results